Dirk Bremen

Impact of Gastric Emptying on Levodopa Pharmacokinetics in Parkinson Disease Patients

Thomas M ller, C. Coronado Erdmann, Dirk Bremen et al. · Clinical Neuropharmacology · 2006 · 128 citations

Levodopa Pharmacokinetics, Medicine, Parkinson Disease +9

Cooperative Interception of Neuronal Apoptosis by BCL‐2 and BAG‐1 Expression: Prevention of Caspase Activation and Reduced Production of Reactive Oxygen Species

Jörg B. Schulz, Dirk Bremen, John C. Reed et al. · Journal of Neurochemistry · 1997 · 107 citations · Full text

Hypericin-induced apoptosis of human malignant glioma cells is light-dependent, independent of bcl-2 expression, and does not require wild-type p53

Michael Weller, Martin Trepel, Cornelia Grimmel et al. · Neurological Research · 1997 · 68 citations

Inhibition of catechol‐<i>O</i>‐methyltransferase contributes to more stable levodopa plasma levels

Thomas Müller, C. Coronado Erdmann, Siegfried Muhlack et al. · Movement Disorders · 2005 · 54 citations

Plasma Half-life, Molecular Pharmacology, Biochemistry +14

Pharmacokinetic behaviour of levodopa and 3-O-methyldopa after repeat administration of levodopa/carbidopa with and without entacapone in patients with Parkinson’s disease

Thomas Müller, C. Coronado Erdmann, Siegfried Muhlack et al. · Journal of Neural Transmission · 2006 · 51 citations

Pharmacokinetic Behaviour, Repeat Administration, Medicine +6